Sparks commentary - Kooth

Healthcare

Sparks - Kooth

More on this equity
Kooth (AIM: KOO) – Margin step-up funds renewed growth investment
Published by Arron Aatkar, PhD

Kooth’s H126 results show a sharp improvement in profitability despite modest top-line pressure: revenue fell 3.9% to £30.8m, or 2% at constant currency, as FX, the planned tapering of California product development revenue, and UK churn outweighed a £0.5m contribution from Michigan. ARR rose 1.9% on a reported basis to £62.9m, although constant-currency ARR slipped 0.5% to £61.4m, with reported net revenue retention of 99%. Gross margin expanded 11.3pp to 74.1% as California direct marketing spend normalised, driving a 102% increase in adjusted EBITDA to £5.3m and a swing to £2.0m profit after tax from a £1.3m loss. Cash generation also improved, leaving Kooth debt-free with £23.1m of net cash and an undrawn $9.5m working-capital facility.

Operationally, California remains the core proof point, with Soluna registrations exceeding 187k at end-June versus more than 130k a year earlier, while independent outcome validation, American Psychological Association ‘Gold’ accreditation and a joint state directive encouraging school-district integration further strengthen its position. Kooth has also broadened its US footprint to three states, with Michigan contributing £0.5m in H126, and New Jersey continuing to grow under its renewed contract. Post-period end, Soluna was successfully launched in the UK across Kooth’s contracts, providing enhanced outcome reporting and product flexibility, while initial Department for Work and Pensions NEET (Not in Education, Employment, or Training) contracts offer an early route to payer diversification.

Management continues to expect underlying FY26 results broadly in line with expectations before FX effects, although it plans to increase investment in H226 to further embed Soluna in California, meaning the H126 margin improvement should not simply be extrapolated. Near-term execution therefore centres on converting the US state pipeline, while the multi-payer Alliance Model is being developed to broaden funding sources, with positive results expected from 2027. Key watchpoints are continued sterling strength, given c 73% of group revenue is US dollar-denominated, and the pace of pipeline conversion, while the stronger cash position provides ample capacity to fund the next phase of growth.

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.